Home SLCO1B1 gene variability influences lipid-lowering efficacy on simvastatin therapy in Southern Brazilians
Article
Licensed
Unlicensed Requires Authentication

SLCO1B1 gene variability influences lipid-lowering efficacy on simvastatin therapy in Southern Brazilians

  • Vinicius A. Sortica , Marilu Fiegenbaum , Luciana O. Lima , Cézar R. Van der Sand , Luis C. Van der Sand , Maria E.W. Ferreira , Renan C. Pires and Mara H. Hutz EMAIL logo
Published/Copyright: March 1, 2012

Abstract

Background:Variants in uptake and efflux transporters can influence diverse statin pharmacokinetics in different populations. This study aimed to investigate the influence of SLCO1B1 gene polymorphism on simvastatin treatment efficacy in a Brazilian population of European ancestry.

Methods: Two hundred and sixteen hypercholesterolemic patients were treated with 20 mg/day simvastatin for 6 months. Plasma lipid and lipoprotein levels were measured at baseline and after 2 and 6 months of treatment. The single nucleotide polymorphisms (SNPs) c.388A>G, c.463C>A and c.521T>C at SLCO1B1 gene were determined by allelic discrimination with TaqMan 5'-nuclease assays. The 388G allele was observed in 160 patients, the 521 C allele was observed in 64 individuals, whereas 61 subjects were 463 A allele carriers.

Results: Carriers of the SLCO1B1 388G allele had a greater reduction of total cholesterol and LDL cholesterol with simvastatin treatment, when compared with 56 388A homozygotes (–28.8% vs. –15.8%, p=0.005 and –39.0% vs. –30.6%, p=0.003; respectively). The c.463C>A and c.521T>C SNPs were not associated with simvastatin treatment. The SLCO1B1 haplotypes showed no statistically significant differences in mean percentage reductions in lipid and lipoprotein levels after simvastatin treatment.

Conclusions: The present study suggests that the SLCO1B1 c.388A>G polymorphism could play a role in the inter-individual variation of clinical response to simvastatin in Brazilians. These results add to those that suggest that the effects of SLCO1B1 variants may be statin specific.


Corresponding author: Professor Mara H. Hutz, Departamento de Genética, Instituto de Biociências, UFRGS, Caixa Postal 15053, 91501-970 Porto Alegre, RS, Brazil Phone: +55 51 3316-6720, Fax: +55 51 3316-7311

Received: 2011-6-20
Accepted: 2011-11-7
Published Online: 2012-03-01
Published in Print: 2012-03-01

©2012 by Walter de Gruyter Berlin Boston

Articles in the same Issue

  1. Editorials
  2. An appeal to medical journal editors: the need for a full description of laboratory methods and specimen handling in clinical study reports
  3. Cancer diagnosis: from dogs to DNA or from DNA to dogs?
  4. The never-ending search of an acceptable compromise for pancreatic lipase standardisation
  5. Review
  6. Hereditary breast cancer: beyond BRCA genetic analysis; PALB2 emerges
  7. Mini Review
  8. Canine olfactory detection of cancer versus laboratory testing: myth or opportunity?
  9. Genetics and Molecular Diagnostics
  10. SLCO1B1 gene variability influences lipid-lowering efficacy on simvastatin therapy in Southern Brazilians
  11. Elevated plasma matrix metalloproteinase-9 protein and its gene polymorphism in patients with community-acquired pneumonia
  12. General Clinical Chemistry and Laboratory Medicine
  13. Minimum analytical quality specifications of inter-laboratory comparisons: agreement among Spanish EQAP organizers
  14. Monitoring quality indicators in laboratory medicine does not automatically result in quality improvement
  15. Speed of sample transportation by a pneumatic tube system can influence the degree of hemolysis
  16. 1,2-Dioleoylglycerol method for pancreatic lipase catalytic activity in serum
  17. Serum lactate dehydrogenase levels significantly correlate with radiological extent of disease and spirometric values in patients with silicosis due to denim sandblasting
  18. Clinical comparison of new monoclonal antibody-based nephelometric assays for free light chain kappa and lambda to polyclonal antibody-based assays and immunofixation electrophoresis
  19. The relationship between antinuclear antibody data and antibodies against extractable nuclear antigens in a large laboratory cohort
  20. Anti-neutrophil cytoplasmic antibodies (ANCA) specific for one or several antigens: useful markers for subtypes of ulcerative colitis and associated primary sclerosing cholangitis
  21. Trueness in the measurement of haemoglobin: consensus or reference method?
  22. Soluble transcobalamin receptor, sCD320, is present in human serum and relates to serum cobalamin – establishment and validation of an ELISA
  23. An on-line solid phase extraction procedure for the routine quantification of caspofungin by liquid chromatography-tandem mass spectrometry
  24. Effects of subcutaneous low molecular weight heparin and intravenous unfractionated heparin on serum S100 concentrations in patients with cerebrovascular diseases
  25. Urinary 8-hydroxy-2′-deoxyguanosine level and plasma paraoxonase 1 activity with Alzheimer’s disease
  26. A HPLC-MS method to detect and quantify guanfacine in urine
  27. Collection and storage requirements for urinary kidney injury molecule-1 (KIM-1) measurements in humans
  28. Kidney stones in a Mediterranean population from the south of Spain
  29. Reference Values and Biological Variations
  30. First trimester biochemistry at different maternal ages
  31. Age- and gender-related alteration in plasma advanced oxidation protein products (AOPP) and glycosaminoglycan (GAG) concentrations in physiological ageing
  32. Cancer Diagnostics
  33. Direct sequencing in cytological specimens as a useful strategy for detecting EGFR mutations in non-small cell lung cancer patients
  34. Investigation of lung cancer biomarkers by hyphenated separation techniques and chemometrics
  35. Letters to the Editor
  36. Aberrant results observed with four immuno-assays for total and free prostate-specific antigen (PSA) determination: a case-report
  37. Assay-dependent abnormalities in measurements of prostate-specific antigen in serum: an occasional occurrence, but of clinical significance
  38. Clinical comparison of new monoclonal antibody-based nephelometric assays for free light chain κ and λ to polyclonal antibody-based assays and immunofixation electrophoresis
  39. Agarose-gel electrophoresis for the diagnosis of mucopolysaccharidoses
  40. Leptin levels in exhaled breath condensate from asthmatic children: a pilot study
  41. Masthead
  42. Masthead
Downloaded on 16.9.2025 from https://www.degruyterbrill.com/document/doi/10.1515/cclm.2011.804/html
Scroll to top button